Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonography

Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonography - Contrast-enhanced ultrasonography for malignant lymphoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024619

Enrollment

Registered

2016-10-31

Start date

2013-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients with histological confirmed malignant lymphoma 2) target lesion can be depicted by ultrasonography 3) hospiterized patient 4) patients who consented to participate in this study

Exclusion criteria

Exclusion criteria: 1) history of allergy to Sonazoid 2) history of allergy to egg 3) not eligible for this study judged by doctors

Design outcomes

Primary

Measure	Time frame
Comparison between some parameters (Time to peak, Area under the curve, etc.) obtained by contrast-enhanced ultrasonography 3, 7, 14 days after start of chemotherapy and response rate.	—

Secondary

Measure	Time frame
Comparison between tissue stiffness obtained by elastography 3, 7, 14 days after start of chemotherapy and response rate.	—

Countries

Japan

Contacts

Public ContactNaoki Matsumoto

Nihon University School of Medicine, Itabashi Hospital Division of Gastroenterology and Hepatology, Department of Medicine

matsumotosg7@gmail.com03-3972-8111

Outcome results